Based on the SMILES representation O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1, the molecule has a drug half life time in humans after IV administration of 38.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
[5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-7-yl]-oxido-oxoazanium